Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

No abstract is available for this paper.

• Publication year

  2017

• Venue

  American Journal of Surgical Pathology

• Publication date

  2017-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/PAS.0000000000000820PMID 28177964
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PREDICTION OF PROGNOSIS FOR PROSTATIC ADENOCARCINOMA BY COMBINED HISTOLOGICAL GRADING AND CLINICAL STAGING

  2017cited by this paper
• Clinical significance of prospectively assigned Gleason tertiary pattern 4 in contemporary Gleason score 3+3=6 prostate cancer

  2016cited by this paper
• Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer

  2016cited by this paper
• Size-adjusted Quantitative Gleason Score as a Predictor of Biochemical Recurrence after Radical Prostatectomy.

  2016cited by this paper
• Clinical Utility of Quantitative Gleason Grading in Prostate Biopsies and Prostatectomy Specimens.

  2016cited by this paper
• Prognostic Significance of Percentage and Architectural Types of Contemporary Gleason Pattern 4 Prostate Cancer in Radical Prostatectomy

  2016cited by this paper
• Active Surveillance for the Management of Localized Prostate Cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement.

  2016cited by this paper
• Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsy

  2016cited by this paper
• WHO Classification of of Tumours of the Urinary System and Male Genital Organs

  2016cited by this paper
• Validation of a contemporary prostate cancer grading system using prostate cancer death as outcome

  2016cited by this paper
• Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence.

  2016cited by this paper
• Interobserver Reproducibility of Percent Gleason Pattern 4 in Prostatic Adenocarcinoma on Prostate Biopsies

  2016cited by this paper
• Utility of Reporting the Percentage of High-grade Prostate Cancer.

  2016cited by this paper
• Histologic Grading of Prostatic Adenocarcinoma Can Be Further Optimized: Analysis of the Relative Prognostic Strength of Individual Architectural Patterns in 1275 Patients From the Canary Retrospective Cohort

  2016cited by this paper
• Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.

  2015cited by this paper
• The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System

  2015cited by this paper
• Active surveillance for the management of localized prostate cancer: Guideline recommendations.

  2015cited by this paper
• Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancer

  2015cited by this paper
• Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy

  2015cited by this paper
• Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohort.

  2014cited by this paper
• Re-evaluating the concept of “dominant/index tumor nodule” in multifocal prostate cancer

  2014cited by this paper
• Significance of the cribriform pattern in prostatic adenocarcinomas.

  2014cited by this paper
• A tertiary Gleason pattern in the prostatectomy specimen and its association with adverse outcome after radical prostatectomy.

  2014cited by this paper
• The association of the cribriform pattern with outcome for prostatic adenocarcinomas.

  2014cited by this paper
• A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy.

  2013cited by this paper
• Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.

  2013cited by this paper
• Prognostic Gleason grade grouping: data based on the modified Gleason scoring system

  2013cited by this paper
• An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011

  2013cited by this paper
• Architectural Heterogeneity and Cribriform Pattern Predict Adverse Clinical Outcome for Gleason Grade 4 Prostatic Adenocarcinoma

  2013cited by this paper
• Digital quantification of five high-grade prostate cancer patterns, including the cribriform pattern, and their association with adverse outcome.

  2011cited by this paper
• Overall and worst gleason scores are equally good predictors of prostate cancer progression

  2011cited by this paper
• Tertiary Gleason pattern 5 and oncological outcomes after radical prostatectomy.

  2011cited by this paper
• Multiple prostate cancer cores with different Gleason grades submitted in the same specimen container without specific site designation: should each core be assigned an individual Gleason score?

  2009cited by this paper
• Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system.

  2009cited by this paper
• Significance of tertiary Gleason pattern 5 in Gleason score 7 radical prostatectomy specimens.

  2008cited by this paper
• Tertiary Gleason pattern 5 in Gleason 7 prostate cancer predicts pathological stage and biochemical recurrence.

  2008cited by this paper
• Impact of reporting rules of biopsy Gleason score for prostate cancer

  2008cited by this paper
• Evaluation of concordance of Gleason score between prostatectomy and biopsies that show more than two different Gleason scores in positive cores.

  2006cited by this paper
• Tertiary Gleason pattern 5 is a powerful predictor of biochemical relapse in patients with Gleason score 7 prostatic adenocarcinoma.

  2006cited by this paper
• Preoperative prediction of Gleason grade in radical prostatectomy specimens: the influence of different Gleason grades from multiple positive biopsy sites

  2005cited by this paper
• The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma

  2005cited by this paper
• Predicting the presence and side of extracapsular extension: a nomogram for staging prostate cancer.

  2004cited by this paper
• Does the tertiary Gleason pattern influence the PSA progression-free interval after retropubic radical prostatectomy for organ-confined prostate cancer?

  2004cited by this paper
• Should each core with prostate cancer be assigned a separate gleason score?

  2003cited by this paper
• Percent Gleason grade 4/5 as prognostic factor in prostate cancer diagnosed at transurethral resection.

  2002cited by this paper
• AJCC Cancer Staging Manual

  2002cited by this paper
• The prognostic significance of tertiary Gleason patterns of higher grade in radical prostatectomy specimens: a proposal to modify the Gleason grading system.

  2000cited by this paper
• Gleason score 2-4 adenocarcinoma of the prostate on needle biopsy: a diagnosis that should not be made.

  2000cited by this paper
• HISTOLOGICAL GRADE HETEROGENEITY IN MULTIFOCAL PROSTATE CANCER. BIOLOGICAL AND CLINICAL IMPLICATIONS

  1996cited by this paper
• Histologic grading of prostate cancer: a perspective.

  1992cited by this paper
• Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging.

  1974cited by this paper
• Classification of prostatic carcinomas.

  1966cited by this paper
• Survival rates of patients with prostatic cancer, tumor stage, and differentiation--preliminary report.

  1966cited by this paper

• Incorporation of grade into stage in oral cavity squamous cell carcinoma: A novel staging schema.

  2026cites this paper
• Spatial multi-omics identifies aggressive prostate cancer signatures highlighting pro-inflammatory chemokine activity in the tumor microenvironment

  2025cites this paper
• Evaluating the Safety of Delaying Surgery Beyond 9 Months in Localized Prostate Cancer Patients: Results From a Prospective Study With Propensity Score Matching

  2025cites this paper
• Low heterogeneity of tumor grades in multiple MRI-targeted prostate biopsies argues for the aggregate method of grading

  2025cites this paper
• Utility of tumor diameter-to-prostate volume ratio for predicting the outcome of magnetic resonance imaging/transrectal ultrasound fusion-targeted biopsy.

  2025cites this paper
• SIU-ICUD: Localized Prostate Cancer: Pathological Factors That Influence Outcomes and Management

  2025cites this paper
• Age-Specific Impact of Cribriform Pattern in Prostate Cancer Following Radical Prostatectomy

  2025cites this paper
• Synthetic MRI as a T2WI alternative in bp-MRI: comparable image quality and improved PI-RADS performance.

  2025cites this paper
• An MRI–pathology foundation model for noninvasive diagnosis and grading of prostate cancer

  2025cites this paper
• Non-invasive MRI-based assessment of reactive stromal grade in prostate cancer using diffusion kurtosis imaging and stretched-exponential model

  2025cites this paper
• Differentiation of high risk prostate cancer with a facile urinary exosome detection workflow

  2025cites this paper
• Risk Stratification of Prostate Cancer: Preoperatively Assessing Aggressiveness of Favorable and Unfavorable Intermediate-Risk Groups by Advanced Diffusion-Weighted Imaging

  2025cites this paper
• Utilidad del PSA en vesículas extracelulares como biomarcador de seguimiento en el cáncer de próstata

  2025cites this paper
• Impact of Cribriform Pattern on Progression-Free Survival After Radical Prostatectomy in Gleason Score 8-10 Prostate Cancer

  2025cites this paper
• Combining Prostate‐Specific Antigen Density With PI‐RADS to Improve the Detection of Clinically Significant Prostate Cancer at MRI/TRUS Fusion‐Targeted Re‐Biopsy

  2025cites this paper
• The state of the art in artificial intelligence and digital pathology in prostate cancer

  2025cites this paper
• Artificial intelligence-assisted enhancement of prostate volume metrics in the diagnosis of clinically significant prostate cancer: a retrospective analysis

  2025cites this paper
• Time to Rethink Gleason Grading.

  2025cites this paper
• Comparison of 5 T and 3 T Biparametric MRI for Clinically Suspected Prostate Cancer: Image Quality, Lesion Visualization, and Artifacts

  2025cites this paper
• Pattern and Distribution of Skeletal Metastases in Patients With Prostate Cancer in Ghana: A Descriptive Analysis and a Model-Based Digital Nomogram for Oligo-Ostotic Versus Polyostotic Metastases

  2025cites this paper
• Utility of PSA in extracellular vesicles as a follow-up biomarker in prostate cancer

  2025cites this paper
• Clinical Feasibility of 3-D Acoustic Radiation Force Impulse (ARFI) Imaging for Targeted Prostate Biopsy Guidance

  2025cites this paper
• The value of the magnetic resonance apparent diffusion coefficient in predicting Gleason grouping upgrading after radical prostatectomy

  2025cites this paper
• External validation of nomograms including PSMA PET information for the prediction of lymph node involvement of prostate cancer

  2025cites this paper
• Impact of Androgen Deprivation Therapy on Choroidal Microcirculation Assessed Using Laser Speckle Flowgraphy

  2025cites this paper
• Multiparametric MRI to Predict Gleason Score Upgrading and Downgrading at Radical Prostatectomy Compared to Presurgical Biopsy

  2025cites this paper
• Functional Outcomes in Patients With Prostate Cancer Undergoing Frozen Section Guided Radical Prostatectomy

  2025cites this paper
• Comparison of biparameter and multiparameter MRI in detection of clinically significant prostate cancer across PSA stratifications

  2025cites this paper
• Reactive Stroma and Acinar Morphology in Prostate Cancer: Implications for Progression and Prognostic Assessment

  2024cites this paper
• Spatial transcriptomics reveals strong association between SFRP4 and extracellular matrix remodeling in prostate cancer

  2024cites this paper
• Values of multiparametric and biparametric MRI in diagnosing clinically significant prostate cancer: a multivariate analysis

  2024cites this paper
• Deep phenotyping of the prostate tumor microenvironment reveals molecular stratifiers of relapse linked to inflammatory chemokine expression and aberrant metabolism

  2024cites this paper
• UPCARE: Urinary Extracellular Vesicles‐Derived Prostate Cancer Assessment for Risk Evaluation

  2024cites this paper
• Comparisons of three scoring systems based on biparametric magnetic resonance imaging for prediction of clinically significant prostate cancer

  2024cites this paper
• Prostate cancer screening; empirical clinical practice conducted for 70 years

  2024cites this paper
• Prognostic significance of invasive cribriform gland size and percentage in Gleason score 7 prostate adenocarcinoma.

  2024cites this paper
• Proposal for an optimised definition of adverse pathology (unfavourable histology) that predicts metastatic risk in prostatic adenocarcinoma independent of grade group and pathological stage

  2024cites this paper
• Machine learning discrimination of Gleason scores below GG3 and above GG4 for HSPC patients diagnosis

  2024cites this paper
• Characterization of prostatic cancer lesion and gleason grade using a continuous-time random-walk diffusion model at high b-values

  2024cites this paper
• A phase IIb randomized placebo-controlled trial testing the effect of MAG-EPA long-chain omega-3 fatty acid dietary supplement on prostate cancer proliferation

  2024cites this paper
• Prognostic Significance of the Cribriform Pattern in Prostate Cancer: Clinical Outcomes and Genomic Alterations

  2024cites this paper
• The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids

  2024cites this paper
• Contemporary Diagnostic Reporting for Prostatic Adenocarcinoma: Morphologic Aspects, Molecular Correlates, and Management Perspectives

  2024cites this paper
• Do 5-Alpha Reductase Inhibitors Influence the Features of Suspicious Lesions on Magnetic Resonance Imaging and Targeted Biopsy Results for Prostate Cancer Diagnosis?

  2024cites this paper
• Contemporary Strategies for Clinical Chemoprevention of Localized Prostate Cancer

  2024cites this paper
• PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4–10 ng/ml

  2024cites this paper
• Long term evaluation of optimized Gleason grading in a large cohort of men with prostate cancer in Canada.

  2024cites this paper
• A nomogram based on biparametric magnetic resonance imaging for detection of clinically significant prostate cancer in biopsy-naïve patients

  2023cites this paper
• A urine extracellular vesicle lncRNA classifier for high-grade prostate cancer and increased risk of progression: A multi-center study

  2023cites this paper
• Quantitative Evaluation of Apparent Diffusion Coefficient Values, ISUP Grades and Prostate-Specific Antigen Density Values of Potentially Malignant PI-RADS Lesions

  2023cites this paper
• Inhibition of the Cyclin K‐CDK12 complex induces DNA damage and increases the effect of androgen deprivation therapy in prostate cancer

  2023cites this paper
• Head‐to‐head: how many categories for grading urothelial carcinoma?

  2023cites this paper
• Outcomes of a Diagnostic Pathway for Prostate Cancer Based on Biparametric MRI and MRI-Targeted Biopsy Only in a Large Teaching Hospital

  2023cites this paper
• Transcriptomic analyses of localized prostate cancers of East Asian and North American men reveal race‐specific luminal‐basal and microenvironmental differences

  2023cites this paper
• The Prognostic Significance of Selected HLA Alleles on Prostate Cancer Outcome

  2023cites this paper
• circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis

  2023cites this paper
• Is prostatic adenocarcinoma with cribriform architecture more difficult to detect on prostate MRI?

  2023cites this paper
• Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer

  2023cites this paper
• Accelerating Cancer Histopathology Workflows with Chemical Imaging and Machine Learning

  2023cites this paper
• Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy

  2023cites this paper
• Exploration of the diagnostic capacity of PSAMR combined with PI-RADS scoring for clinically significant prostate cancer and establishment and validation of the Nomogram prediction model

  2023cites this paper
• The Impact of Multiparametric Magnetic Resonance Imaging on Treatment Strategies for Incidental Prostate Cancer after Holmium Laser Enucleation of the Prostate

  2023cites this paper
• Research of Prostate Cancer Urinary Diagnostic Biomarkers by Proteomics: The Noteworthy Influence of Inflammation

  2023cites this paper
• Role of [^68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer

  2023cites this paper
• A scoring diagnostic system based on biparametric ultrasound features for prostate cancer risk assessment

  2023influential citation
• Deep Learning Algorithm for Tumor Segmentation and Discrimination of Clinically Significant Cancer in Patients with Prostate Cancer

  2023cites this paper
• Risk stratification for early biochemical recurrence of prostate cancer in the era of multiparametric magnetic resonance imagining‐targeted biopsy

  2023cites this paper
• Effects of Dynamic Contrast Enhancement on Transition Zone Prostate Cancer in Prostate Imaging Reporting and Data System Version 2.1

  2023cites this paper
• Multimodal convolutional neural networks based on the Raman spectra of serum and clinical features for the early diagnosis of prostate cancer.

  2023cites this paper
• The function of Prostate Health Index in detecting clinically significant prostate cancer in the PI-RADS 3 population: a multicenter prospective study

  2023cites this paper
• Analytical exploratory tool for healthcare professionals to monitor cancer patients’ progress

  2023cites this paper
• Impact of changing PI-RADS cutoff on prostate cancer detection by MRI cognitive fusion biopsy in biopsy-naïve patients

  2023cites this paper
• Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancer

  2023cites this paper
• PSA reactivity in extracellular microvesicles to commercial immunoassays.

  2023cites this paper
• Characterization of metabolism-associated molecular patterns in prostate cancer

  2023cites this paper
• Comparative impact of grade on mortality across salivary cancers: A novel, unifying staging system

  2023cites this paper
• Pro-tumorigenic role of lnc-ZNF30-3 as a sponge counteracting miR-145-5p in prostate cancer

  2023cites this paper
• Higher Preoperative Maximum Standardised Uptake Values (SUVmax) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [68Ga]Ga-PSMA-11 and [18F]DCFPyL Positron Emission Tomography/Computed Tomography

  2023cites this paper
• Sub-differentiation of PI-RADS 3 lesions in TZ by advanced diffusion-weighted imaging to aid the biopsy decision process

  2023cites this paper
• Tumour grading: communication is the key

  2023cites this paper
• Evaluation of automatic discrimination between benign and malignant prostate tissue in the era of high precision digital pathology

  2023cites this paper
• Deep Learning Methodologies Applied to Digital Pathology in Prostate Cancer: A Systematic Review

  2023cites this paper
• Variation in patient reported outcomes following radical prostatectomy: A bi-national registry-based study.

  2022cites this paper
• Modified the 8th AJCC staging system for patients with advanced prostate cancer: a study based on SEER database

  2022cites this paper
• MRI-Derived Apparent Diffusion Coefficient of Peri-Prostatic Adipose Tissue Is a Potential Determinant of Prostate Cancer Aggressiveness in Preoperative Setting: A Preliminary Report

  2022cites this paper
• Multi-Stage Classification-Based Deep Learning for Gleason System Grading Using Histopathological Images

  2022cites this paper
• A Comparative Study of Multiparametric MRI Sequences in Measuring Prostate Cancer Index Lesion Volume

  2022cites this paper
• Clonal Relationships of Adjacent Gleason Pattern 3 and Gleason Pattern 5 Lesions in Gleason Scores 3+5=8 and 5+3=8.

  2022cites this paper
• Single cell analysis of cribriform prostate cancer reveals cell intrinsic and tumor microenvironmental pathways of aggressive disease

  2022cites this paper
• Construction and validation of web-based nomograms for detecting and prognosticating in prostate adenocarcinoma with bone metastasis

  2022cites this paper
• Use of the ISUP e-learning module improves interrater reliability in prostate cancer grading

  2022cites this paper
• Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis

  2022cites this paper
• Development of a Prediction Model for Positive Surgical Margin in Robot-Assisted Laparoscopic Radical Prostatectomy

  2022cites this paper
• The Cellular and Molecular Immunotherapy in Prostate Cancer

  2022cites this paper
• Grading of prostate cancer: Evolution and changing concepts

  2022cites this paper
• Canadian Association of Radiologists Prostate MRI White Paper

  2022cites this paper
• Blood prostate-specific antigen by volume of benign, Gleason pattern 3 and 4 prostate tissue.

  2022cites this paper
• Increased Density of Growth Differentiation Factor-15+ Immunoreactive M1/M2 Macrophages in Prostate Cancer of Different Gleason Scores Compared with Benign Prostate Hyperplasia

  2022cites this paper
• Rapid Histological Assessment of Prostate Specimens in the Three-dimensional Space by Hydrophilic Tissue Clearing and Confocal Microscopy

  2022cites this paper
• Clinical utility of histopathology data: urological cancers

  2022cites this paper